← Open Payments lookup

JUSTIN CRAWFORD: Open Payments

NPI 1871229757 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,904 in 47 payments from 7 companies in 2025. Trend: 2023 $583 · 2024 $1,044 · 2025 $3,904

Consulting: $2,060Food & beverage: $1,500Travel & lodging: $345
CompanyPaymentsAmount
Gilead Sciences, Inc.21$3,246
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$178
Madrigal Pharmaceuticals6$176
Intercept Pharmaceuticals, Inc.3$153
Ipsen Biopharmaceuticals, Inc4$105
Eton Pharmaceuticals, Inc.1$25
ORPHALAN INC1$21

Products named: Livdelzi, XIFAXAN, REZDIFFRA, OCALIVA, IQIRVO, GALZIN, CUVRIOR.

Industry payments across TX — which companies pay providers there.